| Geriatric Inpatient Services Of Kansas Llc | |
|
7447 W Village Cir Wichita KS 67205-2625 | |
| (316) 372-8892 | |
| Not Available |
| Full Name | Geriatric Inpatient Services Of Kansas Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 7447 W Village Cir, Wichita, Kansas |
| Authorized Official Name and Position | Alison Raymond (MEDICAL DIRECTOR) |
| Authorized Official Contact | 3162853705 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Geriatric Inpatient Services Of Kansas Llc 2918 N Parkdale Ct Wichita KS 67205-6039 Ph: () - | Geriatric Inpatient Services Of Kansas Llc 7447 W Village Cir Wichita KS 67205-2625 Ph: (316) 372-8892 |
| NPI Number | 1073293650 |
|---|---|
| Provider Enumeration Date | 07/19/2023 |
| Last Update Date | 07/19/2023 |
| Medicare PECOS PAC ID | 4587011192 |
|---|---|
| Medicare Enrollment ID | O20231103000426 |
News Archive
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.
Pfizer Inc. announced today that the European Commission has approved SUTENT (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with disease progression in adults.
The Associated Press/Miami Herald: Florida health officials announced they will "begin using voice recognition technology to verify whether patients in Miami-Dade County are actually receiving home health care services the state is being billed for."
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073293650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Alison K Raymond |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1568690022 PECOS PAC ID: 2567587967 Enrollment ID: I20100908000825 |
News Archive
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.
Pfizer Inc. announced today that the European Commission has approved SUTENT (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with disease progression in adults.
The Associated Press/Miami Herald: Florida health officials announced they will "begin using voice recognition technology to verify whether patients in Miami-Dade County are actually receiving home health care services the state is being billed for."
› Verified 7 days ago
| Provider Name | Julie V Ashbrook Deering |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124454483 PECOS PAC ID: 1951531169 Enrollment ID: I20140310001533 |
News Archive
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.
Pfizer Inc. announced today that the European Commission has approved SUTENT (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with disease progression in adults.
The Associated Press/Miami Herald: Florida health officials announced they will "begin using voice recognition technology to verify whether patients in Miami-Dade County are actually receiving home health care services the state is being billed for."
› Verified 7 days ago
| Provider Name | Stacey Lynn Wood |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396320958 PECOS PAC ID: 0042608929 Enrollment ID: I20211026001687 |
News Archive
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.
Pfizer Inc. announced today that the European Commission has approved SUTENT (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with disease progression in adults.
The Associated Press/Miami Herald: Florida health officials announced they will "begin using voice recognition technology to verify whether patients in Miami-Dade County are actually receiving home health care services the state is being billed for."
› Verified 7 days ago
News Archive
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
Internationally, severe asthma is defined as anybody who is on maximum therapy, which has no measurable side effects, but still have symptoms of persistent asthma. In the UK, that effectively means people who require oral steroids for their asthma two or more times a year.
Pfizer Inc. announced today that the European Commission has approved SUTENT (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumors (NET) with disease progression in adults.
The Associated Press/Miami Herald: Florida health officials announced they will "begin using voice recognition technology to verify whether patients in Miami-Dade County are actually receiving home health care services the state is being billed for."
› Verified 7 days ago
Primary Care Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7111 E 21st St N Ste A, Wichita, KS 67206 Phone: 316-684-2851 | |
Substance Abuse At Hunter Health Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2318 E Central Ave, Wichita, KS 67214 Phone: 316-262-3611 Fax: 316-262-0741 | |
Freestate Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4723 E Douglas Ave, Wichita, KS 67218 Phone: 888-505-1776 Fax: 888-505-1776 | |
Robert A Sweet Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3122 N Cypress Dr, Suite 100, Wichita, KS 67226 Phone: 316-260-4747 | |
World Impact, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3701 E 13th St N, #400, Wichita, KS 67208 Phone: 316-682-1880 | |
The Traveling Np Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 826 N Bracken Cir, Wichita, KS 67206 Phone: 316-990-8848 | |
Healthcore Clinic Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2707 East 21st Street North, Wichita, KS 67214 Phone: 316-691-0249 Fax: 316-691-9939 |